Evaluation of recombinant monoclonal antibody SVmab1 binding to Na V1.7 target sequences and block of human Na V1.7 currents
Identification of small and large molecule pain therapeutics that target the genetically validated voltage-gated sodium channel Na V1.7 is a challenging endeavor under vigorous pursuit. The monoclonal antibody SVmab1 was recently published to bind the Na V1.7 DII voltage sensor domain and block huma...
Main Authors: | Liu, Dong, Tseng, Mandy, Epstein, Linda F., Green, Lydia, Chan, Brian, Soriano, Brian, Lim, Desiree, Pan, Oscar, Murawsky, Christopher M., King, Chadwick T., Moyer, Bryan D. |
---|---|
Format: | Online |
Language: | English |
Published: |
F1000Research
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155501/ |
Similar Items
-
Roles of Voltage-Gated Tetrodotoxin-Sensitive Sodium Channels NaV1.3 and NaV1.7 in Diabetes and Painful Diabetic Neuropathy
by: Yang, Linlin, et al.
Published: (2016) -
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
by: Bryan D Moyer, et al. -
Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7
by: Estacion, Mark, et al.
Published: (2011) -
Splice Variants of NaV1.7 Sodium Channels Have Distinct β Subunit-Dependent Biophysical Properties
by: Farmer, Clare, et al.
Published: (2012) -
NaV1.7: Stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus
by: Black, Joel A, et al.
Published: (2013)